NUTRA PHARMA CORP (NPHC) › Operating Cash FlowNUTRA PHARMA CORP (NPHC) — Operating Cash FlowAnnual figures by fiscal year, from SEC filings.2010: -$1.36M2011: -$1.89M2012: -$721.2K2013: -$531.0K2014: -$148.1K2015: -$1.02M2016: -$1.36M2017: -$1.14M2018: -$999.9K2019: -$743.7K2020: -$878.1K2021: -$1.74M2022: -$762.4K2023: -$550.0K2024: -$424.0K2025: -$1.16M-$1.16M2010Operating Cash Flow (USD)2025Fiscal YearOperating Cash FlowChange YoY2025-$1.16M-174.5%2024-$424.0K+22.9%2023-$550.0K+27.9%2022-$762.4K+56.3%2021-$1.74M-98.7%2020-$878.1K-18.1%2019-$743.7K+25.6%2018-$999.9K+12.2%2017-$1.14M+16.1%2016-$1.36M-33.2%2015-$1.02M-587.4%2014-$148.1K+72.1%2013-$531.0K+26.4%2012-$721.2K+61.8%2011-$1.89M-39.0%2010-$1.36M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per Share